Hyobin LLC
Hyobin LLC appears in FDA public data with 3 recalls, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0383-2021, Class II) was initiated on April 6, 2021.
Summary
- Total Recalls
- 3
- 510(k) Clearances
- 0
- Inspections
- 0
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0383-2021 | Class II | Triple SupremeZen Plus 3500, packaged in cardboard blisters containing one capsule per card, Distr | April 6, 2021 |
| D-0381-2021 | Class II | PremierZen Extreme 3000, packaged in cardboard blisters containing one capsule per card, Distribut | April 6, 2021 |
| D-0382-2021 | Class II | PremierZen Black 5000, packaged in cardboard blisters containing one capsule per card, Distributed | April 6, 2021 |